You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder

Thomas W. Uhde, MD; Murray B. Stein, MD; Bernard J. Vittone, MD; Larry J. Siever, MD; Jean-Philippe Boulenger, MD; Ehud Klein, MD; Thomas A. Mellman, MD

Arch Gen Psychiatry. 1989;46(2):170-177.


Abstract

• We evaluated the behavioral and physiologic effects of clonidine hydrochloride, a centrally active {alpha}2-adrenergic agonist, in two separate studies of patients with panic disorder. In the first study, intravenous clonidine (2 µg/kg) and placebo were administered on a blind basis to 12 patients with panic disorder and ten normal controls. Clonidine produced significantly greater decrements in anxiety at one hour in the patients with panic disorder than in the controls. The changes in pulse, blood pressure, and ratings of sleepiness did not differ significantly between patients and controls. In the second study, oral clonidine was administered to 18 patients in a double-blind, flexible-dose treatment trial averaging ten weeks in duration. While anxiolytic effects were noticed in some patients, these effects did not persist in the group as a whole. These two studies indicate that while clonidine has short-term anxiolytic effects in patients with panic disorder, these effects do not persist with long-term administration in most patients.



Author Affiliations

From the Unit on Anxiety and Affective Disorders, Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Md (Drs Uhde, Stein, Vittone, Klein, and Mellman); and the Bronx Veterans Administration Hospital, Bronx, New York (Dr Siever). At the time of this study, Dr Boulenger was a Visiting Associate with Dr Uhde at the National Institute of Mental Health.


Footnotes

Accepted for publication Sept 10, 1988.

Reprint requests to Unit on Anxiety and Affective Disorders, Biological Psychiatry Branch, NIMH, Room 3S239, Bldg 10, 9000 Rockville Pike, Bethesda, MD 20892 (Dr Uhde).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Panic & Plaques: Panic Disorder & Coronary Artery Disease in Patients with Chest Pain
Katerndahl
J Am Board Fam Med 2004;17:114-126.
ABSTRACT | FULL TEXT  

A comparison of augmenting central serotonin and noradrenaline function in healthy subjects: implications for studies on the neurochemistry of anxiety
Dratcu et al.
J Psychopharmacol 1995;9:127-135.
ABSTRACT  

Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.